How Genomic Testing Can Help Guide Your Treatment Choice
Newer tests of your tumor’s genetic material (called “genomic testing”) can show how aggressive your prostate cancer is, beyond your PSA level and Gleason score. The results can help guide decisions about intensity and length of your therapy.
PCF Chief Medical Officer Dr. Phillip Koo speaks with Dr. Jim Hu (Weill Cornell Medicine), and Dr. Zachary Klaassen (Wellstar MCG Health). Learn about:
- How the Decipher test works—and the strong scientific evidence behind it
- How results complement PSA, MRI, and other tools to guide treatment choices
- How to advocate for yourself when discussing options with your doctor
PCF thanks Veracyte for their support of this event.
